Pure Global
NCT06403423

Screening for Aortic Aneurysms in Inland Norway

Screening for Infra-renal Abdominal Aortic Aneurysms in 65-year-old Men in Inland, Norway
Sykehuset Innlandet HF·ClinicalTrials.govEnrolling by invitation
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Abdominal Aortic Aneurysm,Erectile Dysfunction,Quality of Life
Study type
Observational
Sponsor & location
Primary sponsor
Sykehuset Innlandet HF
Location
Hamar, Norway
Timeline & enrollment
Phase
N/A
Start date
May 14, 2024
End date
Dec 31, 2030
Enrollment
240 participants
Primary outcome

Prevalence,Etiology

Summary

The number of AAA-surgeries performed per capita is 3-4 times higher in Innlandet county, as
 compared to Oslo. The last three years the annual incidence of AAA requiring treatment has
 been 21.5 / 100 000 inhabitants in Innlandet, as compared to 6.6 / 100 000 in Oslo. The
 indication for surgery is the same in both regions. In Oslo, a screening program was
 established in 2011, reporting a prevalence of AAA of 2.6 %, but in Innlandet county all AAA
 are either symptomatic or incidental findings and the prevalence is unknown. The aetiology of
 the major difference in AAA prevalence between these two regions has not been previously
 explored.

ICD-10 classifications
Abdominal aortic aneurysm, rupturedAbdominal aortic aneurysm, without mention of ruptureAneurysm of aorta in diseases classified elsewhereAortic aneurysm of unspecified site, without mention of ruptureAortic aneurysm of unspecified site, ruptured
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06403423
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06403423 through Pure Global AI's free database. This phase not specified trial is sponsored by Sykehuset Innlandet HF and is currently Enrolling by invitation. The study focuses on Abdominal Aortic Aneurysm,Erectile Dysfunction,Quality of Life. Target enrollment is 240 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.